BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28054559)

  • 1. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
    Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
    Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
    Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
    Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion.
    Li H; Peng W; Jian W; Li Y; Li Q; Li W; Xu Y
    Cardiovasc Diabetol; 2012 Jun; 11():65. PubMed ID: 22694757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway.
    Shu A; Du Q; Chen J; Gao Y; Zhu Y; Lv G; Lu J; Chen Y; Xu H
    Chem Biol Interact; 2021 Oct; 348():109625. PubMed ID: 34416245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
    Eisa-Beygi S; Wen XY
    Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction.
    Huang L; Dai F; Tang L; Bao X; Liu Z; Huang C; Zhang T; Yao W
    Cell Physiol Biochem; 2018; 49(2):565-577. PubMed ID: 30165352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy.
    Xie X; Peng J; Chang X; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Apr; 369(1-2):86-97. PubMed ID: 23376009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
    Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
    Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
    PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
    Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
    Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
    Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil alleviates acetaminophen-induced liver injury via targeting Rhoa/ROCK signal pathway.
    Ren X; Meng T; Ren X; Li X; Lu L
    J Toxicol Sci; 2021; 46(6):255-262. PubMed ID: 34078832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Rho/Rho-kinase pathway in the expression of ICAM-1 by linoleic acid in human aortic endothelial cells.
    Jung CH; Lee WJ; Hwang JY; Seol SM; Kim YM; Lee YL; Ahn JH; Park JY
    Inflammation; 2012 Jun; 35(3):1041-8. PubMed ID: 22124782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucocorticoid dexamethasone inhibits U937 cell adhesion and neutrophil release via RhoA/ROCK1-dependent and independent pathways.
    Liu D; Xiong R; Chen X; Li P; Ning Y; Peng Y; Zhao Y; Yang N; Zhou Y
    Cell Physiol Biochem; 2014; 33(6):1654-62. PubMed ID: 24902944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells.
    Matoba K; Kawanami D; Ishizawa S; Kanazawa Y; Yokota T; Utsunomiya K
    Biochem Biophys Res Commun; 2010 Nov; 402(4):725-30. PubMed ID: 20977889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin induces MCP-1 expression through Rho-kinase and subsequent p38MAPK/NF-κB signaling pathway activation in vascular endothelial cells.
    Kawanami D; Matoba K; Kanazawa Y; Ishizawa S; Yokota T; Utsunomiya K
    Biochem Biophys Res Commun; 2011 Aug; 411(4):798-803. PubMed ID: 21787749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
    Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
    Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
    Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.